Respiratory arrest during caesarean section after intrathecal administration of sufentanil in combination with 0.1% bupivacaine 10 ml.
Kehl
F
F
Erfkamp
S
S
Roewer
N
N
D000328:Adult; D000773:Anesthesia, Obstetrical / Q000009:adverse effects* / Q000379:methods; D019162:Anesthetics, Combined; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects*; D002585:Cesarean Section; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D017214:Laryngeal Masks; D010100:Oxygen / Q000627:therapeutic use; D011247:Pregnancy; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D018570:Risk Assessment; D017409:Sufentanil / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
D019162:Anesthetics, Combined; D017409:Sufentanil; D010100:Oxygen; D002045:Bupivacaine